Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusNews Register for New Alert
News for May 2004
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Arrhythmias added to 'ahead of schedule' heart disease NSF
Increase in hypertension a negative..(more)

 NICE strikes deal with industry on data confidentiality
Move towards greater transparency..(more)

 NICE recommendation on Glivec criticised
Novartis alarmed by recommendation..(more)

 Velcade launched in UK
Ortho-Biotech to market cancer drug..(more)

 Sanofi takes charge of arranged marriage
Merged company faces generics threats..(more)

 European biotech revenues fall back
Lack of funding a major problem..(more)

 GSK establishes strategic link with Theravance
GSK increases stake in US biotech..(more)

 AstraZeneca issues Crestor safety warning
Reminder given about dosage levels..(more)

 UCB snaps up arthritis drug and Celltech in one
Deal welcomed by analysts..(more)

 NICE strikes deal with industry on data confidentiality
NICE aims for greater transparency..(more)

 Obesity drug collaboration for BMS and Solvay
BMS looks to build long-term growth..(more)

 Faslodex launched in UK
AstraZeneca adds to oncology franchise..(more)

 GSK sued for 'abandoning' Relenza
Litigation only option for Biota..(more)

 Women returning to HRT
Studies not putting women off HRT..(more)

 TNF-blockers continue to expand indications
Remicade gains preliminary European approval..(more)

 Clinicians still struggling to gain control of NHS
NHS Alliance report calls for change ..(more)

 New laws to combat animal rights extremists
Government says animal research must go ahead..(more)

 Zocor approved for sale over-the-counter
Zocor to go OTC in July..(more)

 Antisoma and Roche's ovarian cancer drug disappoints
Roche positive about Tarceva..(more)

 UK and Ireland spoil Exanta's European approval
Exanta to be a big hit for AstraZeneca..(more)

 Intervention from Paris secures French future for Aventis
E55.3 billion to create new number three..(more)

 OTC Zocor to be cleared but divisions persist
Opponents question dose level..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.